- Home
- AMLX vs HMN Comparison
AMLX vs HMN Comparison
Compare AMLX & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMLX | HMN |
|---|---|---|
| Founded | 2014 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AMLX | HMN |
|---|---|---|
| Price | $14.55 | $44.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $21.56 | ★ $47.33 |
| AVG Volume (30 Days) | ★ 948.4K | 151.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | ★ 65.46 | 57.26 |
| EPS | N/A | ★ 3.90 |
| Revenue | $380,786,000.00 | ★ $1,701,400,000.00 |
| Revenue This Year | N/A | $6.91 |
| Revenue Next Year | N/A | $3.41 |
| P/E Ratio | ★ N/A | $11.61 |
| Revenue Growth | ★ 1612.94 | 6.66 |
| 52 Week Low | $4.64 | $40.04 |
| 52 Week High | $18.61 | $48.33 |
Technical Indicators
Market Signals| Indicator | AMLX | HMN |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | 45.97 |
| Support Level | $13.02 | $43.47 |
| Resistance Level | $15.37 | $45.81 |
| Average True Range (ATR) | 0.86 | 1.06 |
| MACD | -0.32 | -0.18 |
| Stochastic Oscillator | 0.00 | 19.15 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About HMN Horace Mann Educators Corporation
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.